Top Qs
Timeline
Chat
Perspective
2CBFly-NBOMe
Pharmaceutical compound From Wikipedia, the free encyclopedia
Remove ads
2CBFly-NBOMe, also known as NBOMe-2C-B-FLY or as Cimbi-31, is a serotonin receptor modulator of the phenethylamine, DOx, and FLY families. It was indirectly derived from the phenethylamine hallucinogen 2C-B is and related to benzodifurans like 2C-B-FLY and N-benzylphenethylamines like 25B-NBOMe.
Remove ads
Interactions
Pharmacology
Pharmacodynamics
2CBFly-NBOMe acts as a potent partial agonist for the 5-HT2A serotonin receptor subtype.[1][2][3]
History
2CBFly-NBOMe was discovered in 2002,[4] and further researched by Ralf Heim at the Free University of Berlin,[5] and subsequently investigated in more detail by a team at Purdue University led by David E. Nichols.[6]
Society and culture
Legal status
United Kingdom
This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[7]
United States
2CBFly-NBOMe is a controlled substance in Vermont as of January 2016.[8]
See also
References
External links
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads
